This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Cliniphar's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was 円. Cliniphar's 10-Year median PS Ratio is . Therefore, the Median PS Value for today is 円0.00.
As of today (2026-07-07), Cliniphar's share price is 円1450.00. Cliniphar's Median PS Value is 円0.00. Therefore, Cliniphar's Price to Median PS Value for today is 0.00.
The historical rank and industry rank for Cliniphar's Median PS Value or its related term are showing as below:
TSE:432A's Price-to-Median-PS-Value is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 0.71 * Ranked among companies with meaningful Price-to-Median-PS-Value only.
Cliniphar (TSE:432A) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Cliniphar's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
1450.00
/
=
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cliniphar Median PS Value Related Terms
Cliniphar Median PS Value Historical Data
* Premium members only.
The historical data trend for Cliniphar's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cliniphar Median PS Value Chart
Cliniphar Annual Data
Trend
Mar24
Mar25
Mar26
Median PS Value
0.00
0.00
0.00
Cliniphar Semi-Annual Data
Mar24
Mar25
Mar26
Median PS Value
0.00
0.00
0.00
Cliniphar Median PS Value Competitor Comparison
For the Pharmaceutical Retailers subindustry, Cliniphar's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cliniphar Price-to-Median-PS-Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cliniphar's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Cliniphar's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is .
For company reported annually, GuruFocus uses latest annual data as the TTM data. Cliniphar's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was 円.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cliniphar (TSE:432A) has a Median PS Value of 円0.00 as of Jul. 07, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Cliniphar and its competitors.
Is Cliniphar's Median PS Value too high?
Cliniphar's current Median PS Value is 円0.00. Overall, Cliniphar has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Cliniphar's Median PS Value compare to competitors?
Cliniphar's Median PS Value of 円0.00 can be compared against companies in the Healthcare Providers & Services industry. The industry median Median PS Value is 0.71. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Healthcare Providers & Services company?
The median Median PS Value among Healthcare Providers & Services companies is 0.71, based on 263 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Cliniphar and its competitors. For the Healthcare Providers & Services industry, the median Median PS Value is 0.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cliniphar's current Median PS Value is 円0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cliniphar stock overvalued right now?
Cliniphar (TSE:432A) has a current Median PS Value of 円0.00. The current Median PS Value is 円0.00. Cliniphar's overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Cliniphar (TSE:432A), the current Median PS Value is 円0.00 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:432A has been successfully added to your 